GLP-1–Based Therapies and the Exocrine Pancreas: More Light, or Just More Heat?
Open Access
- 13 April 2012
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 61 (5), 986-988
- https://doi.org/10.2337/db11-1838
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12D Mouse ModelDiabetes, 2012
- The Human GLP-1 Analog Liraglutide and the PancreasDiabetes, 2012
- Glucagon Like Peptide-1 Receptor Expression in the Human Thyroid GlandJournal of Clinical Endocrinology & Metabolism, 2012
- Pancreatic ductal cells in development, regeneration, and neoplasiaJCI Insight, 2011
- Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based TherapiesGastroenterology, 2011
- Acute Pancreatitis in Type 2 Diabetes Treated With Exenatide or SitagliptinDiabetes Care, 2010
- Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitisInternational Journal of Clinical Practice, 2010
- GLP-1–Based Therapy for Diabetes: What You Do Not Know Can Hurt YouDiabetes Care, 2010
- Adaptive β-Cell Proliferation Is Severely Restricted With Advanced AgeDiabetes, 2009
- Proliferation of sorted human and rat beta cellsDiabetologia, 2007